Cell Envision--Tumor Immune Microenvironment (TiME) microdissection immunophenotype analyzer

Model: CytoProphet I/O

Exhibitor: NATIONAL TSING HUA UNIVERSITY college of life science biotechnology-application INDUSTRY-ACADEMIA ALLIANCE (NTHU LS BIO-APP)

Booth No: R1020

Characteristic

【Characteristic】
We are the first commercial Patient-Derived Explants (PDEs) platform used for profiling the response assessment and selection to cancer immunotherapy by developed of the single-cell functional multi-omics analytical modules.
If the cellular and molecular properties of the metastatic are seed the same across different tumor types and metastatic sites, lineage analysis techniques are required to quantify the fraction of single-cell versus multicellular immune cell and tumor microenvironment analyses to determine their molecular properties.
To provide a total solution, we are accelerating the discovery of identification & pathogenesis in reproductive medicine and oncology by revealing the true functional biology of every patient's rare cell and its related immuno-microenvironment by our unique Patient-Derived Organoids (PDOs) platform to predict the cancer metastasis and recurrence in patients with lung adenocarcinoma as the first target topic.

【Company Profile】
CellEnvision is a Contract Development and Manufacturing Organization (CDMO) services company for medical LDT lab test and IVD (companion diagnostics) medical devices applied for Personalized Cancer Immunotherapy. We are accelerating the discovery of identification & pathogenesis in reproductive medicine and oncology by revealing the true functional biology of every patient rare cell and its related immuno-microenvironment by our unique Patient-Derived Organoids (PDOs) platform.

【Contact window】
Chun-Hao Lai
masquerade475@gmail.com